Company intelligence / Profile preview

Angel Biotechnology Holdings

Ownership: Private
Development stage: Other

Overview

Angel Biotechnology Holdings plc was a world-class contract biomanufacturing company based in the United Kingdom that specialized in process development and GMP manufacturing of advanced biologics. It offered services for recombinant proteins, antibodies, cell therapies (autologous and allogeneic), stem cells, and vaccines, supporting clients from early-stage development through commercial manufacturing. The company is no longer active, having been dissolved on July 22, 2015, following administration.

Modalities: AntibodyCell therapyProteinRecombinant proteinStem cell therapyVaccine
Industry: Contract Manufacturing Organization

Partnerships

Materia Medica Holding

Beyond the preview

Go deeper on Angel Biotechnology Holdings.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Angel Biotechnology Holdings.